Advertisement

Biological and Hormonal Therapies of Cancer

  • Kenneth A. Foon
  • Hyman B. Muss

Part of the Cancer Treatment and Research book series (CTAR, volume 94)

Table of contents

  1. Front Matter
    Pages i-xiii
  2. William J. John, Kenneth A. Foon
    Pages 23-33
  3. Michael J. Mastrangelo, Takami Sato, Edmund C. Lattime, Henry C. Maguire Jr., David Berd
    Pages 35-50
  4. Malaya Bhattacharya-Chatterjee, Kenneth A. Foon
    Pages 51-68
  5. Rick L. Bare, Frank M. Torti
    Pages 69-87
  6. Samuel S. Lentz
    Pages 89-106
  7. J. Mark Cline, Claude L. Hughes Jr.
    Pages 107-134
  8. Mark R. Olsen, Richard R. Love
    Pages 135-157
  9. Malcolm M. Bilimoria, V. Craig Jordan
    Pages 181-193
  10. Richard R. Barakat
    Pages 195-207
  11. Gretchen G. Kimmick, Hyman B. Muss
    Pages 231-254
  12. Anne T. Ferguson, Rena G. Lapidus, Nancy E. Davidson
    Pages 255-278
  13. Back Matter
    Pages 279-286

About this book

Introduction

This volume, Biological and Hormonal Therapies of Cancer, which is part of the series Cancer Treatment and Research, presents selected new information concerning biologic and hormonal therapy of cancer. We have attempted to provide the reader with topics of major interest in a timely fashion. There is renewed interest in biologic therapy of cancer. Two chapters review the role of interferon in the hematologic malignancies and in solid tumors. Vaccine therapies have come to the forefront of cancer therapy re­ cently, and two chapters approach different strategies of vaccine therapies; one reviews the cellular vaccine therapies and another the anti-idiotype ap­ proach. The hormonal therapy chapters focus on current uses of endocrine therapy in endometrial, breast, and prostate cancer. In addition, hormonal strategies for the prevention of breast cancer and endometrial cancer, including excit­ ing information relating to phytochemicals, are presented. The effects of tamoxifen on endometrium is a topic of major interest and is discussed in detail. Finally, there is a chapter on estrogen receptor expression and regula­ tion in human breast cancer. These chapters are all written by experts in the field and contain timely and relevant information of interest to laboratory and clinical scientists and practitioners alike. Biologic and endocrine therapies represent major areas of cancer research interest. The advent of newer biologic therapies, including new antibody­ targeted treatments, and the use of biologics as tumor modulators to enhance the effects of other treatment regimens is an exploding avenue of research.

Keywords

Tumor adjuvant therapy endometrium hormones interferon prevention prostate cancer

Editors and affiliations

  • Kenneth A. Foon
    • 1
  • Hyman B. Muss
    • 2
  1. 1.Lucille Parker Markey Cancer CenterUniversity of KentuckyLexingtonUSA
  2. 2.College of Medicine, Vermont Cancer CenterUniversity of VermontBurlingtonUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-4615-6189-7
  • Copyright Information Kluwer Academic Publishers 1998
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4613-7837-2
  • Online ISBN 978-1-4615-6189-7
  • Series Print ISSN 0927-3042
  • Buy this book on publisher's site